• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

April 1, 2019

Trending News Today: CAR T Therapy Shows Early Promise for Use in Some Solid Tumors

Author(s):

SPT Staff

Top news of the day from across the health care industry.

A new study suggested that chimeric antigen receptor (CAR) T cell therapy may potentially be able to fight against some solid tumors, The Associated Press reported. According to the article, study researcher Prasad Adusumilli, MD, of Memorial Sloan Kettering Cancer Center, designed a new CAR T therapy and tested it on 19 patients with mesothelioma and 2 others with lung and breast cancer, respectively, that had spread to the chest lining. After therapy, 1 patient was able to have surgery and radiation and 15 other were well enough to begin taking a drug that boosts the immune system in a different way, the article reported. Of the 11 patients who were studied long enough to report results, 2 had signs of cancer disappear for approximately 1 year, 6 saw their tumors shrink, and 3 saw their cancer worsen, according to the findings.

Alcohol and caffeine consumption are the most common behaviors that can trigger episodes of atrial fibrillation (AF), Reuters reported. According to the article, a study published in Heart Rhythm surveyed 1295 patients with symptomatic paroxysmal AF and asked about 11 possible triggers: alcohol, caffeine, lack of sleep, exercise, not exercising, consuming cold beverages, consuming cold foods, high sodium diet, consuming large meals, dehydration, and lying on one’s left side. Alcohol consumption was cited by 35%, followed by coffee drinking (28%), exercise (23%), and lack of sleep (21%), the article reported.

A recent study found that aerobic exercise may be associated with a reduced number of migraine days in patients who experience migraine, The American Journal of Managed Care. According to the article, the authors were able to identify 6 studies that had evaluated the number of migraine days, attack frequency, and pain intensity or duration of migraine attacks. Based on reports from 4 included studies, aerobic exercise was associated with a reduction in the number of migraine days at 10 to 12 weeks, the article reported.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Advertisement
Breast cancer cells | Image Credit: © sknab - stock.adobe.com
August 29th 2025

Abemaciclib Plus Endocrine Therapy Improves Survival in Patients With HR+/HER2– Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 29th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Medication Experts on the Front Line: Pharmacists in Cardio-Oncology Care Pathways
August 29th 2025

Medication Experts on the Front Line: Pharmacists in Cardio-Oncology Care Pathways

Caitlin Raimo, PharmD Candidate
Pharmacy Times, Pharmacy Focus Oncology Edition
August 29th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Oral metformin tablets (CKD) -- Image credit: Sherry Young | stock.adobe.com
August 29th 2025

Metformin, Potential Treatment for ADPKD, Currently Undergoing Investigation in Long-Term Efficacy Trial

Gillian McGovern, Associate Editor
Wegovy injection pens | Image Credit: © Patrick Bay Damsted - stock.adobe.com
August 29th 2025

Study Finds GLP-1 Receptor Agonists May Reduce Cancer Risk in Adults With Obesity

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Breast cancer cells | Image Credit: © sknab - stock.adobe.com
August 29th 2025

Abemaciclib Plus Endocrine Therapy Improves Survival in Patients With HR+/HER2– Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
August 29th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Medication Experts on the Front Line: Pharmacists in Cardio-Oncology Care Pathways
August 29th 2025

Medication Experts on the Front Line: Pharmacists in Cardio-Oncology Care Pathways

Caitlin Raimo, PharmD Candidate
Pharmacy Times, Pharmacy Focus Oncology Edition
August 29th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Oral metformin tablets (CKD) -- Image credit: Sherry Young | stock.adobe.com
August 29th 2025

Metformin, Potential Treatment for ADPKD, Currently Undergoing Investigation in Long-Term Efficacy Trial

Gillian McGovern, Associate Editor
Wegovy injection pens | Image Credit: © Patrick Bay Damsted - stock.adobe.com
August 29th 2025

Study Finds GLP-1 Receptor Agonists May Reduce Cancer Risk in Adults With Obesity

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.